Your browser doesn't support javascript.
loading
Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma.
Pokorny, Rebecca; McPherson, Jordan P; Haaland, Benjamin; Grossmann, Kenneth F; Luckett, Carolyn; Voorhies, Benjamin Newell; Sageser, Daniel S; Wallentine, Jocelyn; Tolman, Zachary; Hu-Lieskovan, Siwen; Swami, Umang.
Afiliación
  • Pokorny R; Department of Pharmacy, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • McPherson JP; Department of Pharmacy, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Haaland B; Division of Oncology and Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Grossmann KF; Department of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Luckett C; Department of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Voorhies BN; Division of Oncology, Department of Medicine, Intermountain Healthcare, Salt Lake City, Utah, USA.
  • Sageser DS; Department of Pharmacy, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Wallentine J; Department of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Tolman Z; Department of Pharmacy, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Hu-Lieskovan S; Department of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Swami U; Department of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA umang.swami@hci.utah.edu.
J Immunother Cancer ; 9(1)2021 01.
Article en En | MEDLINE | ID: mdl-33500258
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos